首页> 外文期刊>Antimicrobial agents and chemotherapy. >Selection during Cefepime Treatment of a New Cephalosporinase Variant with Extended-Spectrum Resistance to Cefepime in an Enterobacter aerogenes Clinical Isolate.
【24h】

Selection during Cefepime Treatment of a New Cephalosporinase Variant with Extended-Spectrum Resistance to Cefepime in an Enterobacter aerogenes Clinical Isolate.

机译:头孢吡肟治疗过程中对新的头孢菌素酶变异体的选择在产气肠杆菌临床分离株中具有对头孢吡肟的广谱耐药性。

获取原文
获取原文并翻译 | 示例
           

摘要

Enterobacter aerogenes resistant to cefepime (MIC, 32 micro g/ml) was isolated from a patient treated with cefepime for an infection caused by a strain of E. aerogenes overproducing its AmpC beta-lactamase (MIC of cefepime, 0.5 micro g/ml). The AmpC beta-lactamase of the resistant strain had an L-293-P amino acid substitution and a high k(cat)/K(m) ratio for cefepime. Both of these modifications were necessary for resistance to cefepime.
机译:从头孢吡肟治疗的患者中分离出对头孢吡肟具有抗药性的产气肠杆菌(MIC,32微克/毫升),该菌是由过度生产其AmpCβ-内酰胺酶的产气链球菌引起的感染(头孢吡肟的MIC,0.5微克/毫升) 。耐药菌株的AmpCβ-内酰胺酶具有L-293-P氨基酸取代和头孢吡肟的高k(cat)/ K(m)比。这两种修饰对于抵抗头孢吡肟都是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号